{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:18:36Z","timestamp":1790313516464,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":80,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Autosomal dominant hypocalcemia type 1 (ADH1) is a rare form of hypoparathyroidism caused by heterozygous, gain-of-function mutations of the calcium-sensing receptor gene (CAR). Individuals are hypocalcemic with inappropriately low parathyroid hormone (PTH) secretion and relative hypercalciuria. Calcilytics are negative allosteric modulators of the extracellular calcium receptor (CaR) and therefore may have therapeutic benefits in ADH1. Five adults with ADH1 due to four distinct CAR mutations received escalating doses of the calcilytic compound NPSP795 (SHP635) on 3 consecutive days. Pharmacokinetics, pharmacodynamics, efficacy, and safety were assessed. Parallel in vitro testing with subject CaR mutations assessed the effects of NPSP795 on cytoplasmic calcium concentrations (Ca2+i), and ERK and p38MAPK phosphorylation. These effects were correlated with clinical responses to administration of NPSP795. NPSP795 increased plasma PTH levels in a concentration-dependent manner up to 129% above baseline (p = 0.013) at the highest exposure levels. Fractional excretion of calcium (FECa) trended down but not significantly so. Blood ionized calcium levels remained stable during NPSP795 infusion despite fasting, no calcitriol supplementation, and little calcium supplementation. NPSP795 was generally safe and well-tolerated. There was significant variability in response clinically across genotypes. In vitro, all mutant CaRs were half-maximally activated (EC50) at lower concentrations of extracellular calcium (Ca2+o) compared to wild-type (WT) CaR; NPSP795 exposure increased the EC50 for all CaR activity readouts. However, the in vitro responses to NPSP795 did not correlate with any clinical parameters. NPSP795 increased plasma PTH levels in subjects with ADH1 in a dose-dependent manner, and thus, serves as proof-of-concept that calcilytics could be an effective treatment for ADH1. Albeit all mutations appear to be activating at the CaR, in vitro observations were not predictive of the in vivo phenotype or the response to calcilytics, suggesting that other parameters impact the response to the drug. \u00a9 2019 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.3747","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:06:59Z","timestamp":1557252419000},"page":"1609-1618","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635)"],"prefix":"10.1093","volume":"34","author":[{"given":"Mary Scott","family":"Roberts","sequence":"first","affiliation":[{"name":"Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research (NIDCR) National Institutes of Health (NIH) Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel I","family":"Gafni","sequence":"additional","affiliation":[{"name":"Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research (NIDCR) National Institutes of Health (NIH) Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Brillante","sequence":"additional","affiliation":[{"name":"Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research (NIDCR) National Institutes of Health (NIH) Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori C","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research (NIDCR) National Institutes of Health (NIH) Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Streit","sequence":"additional","affiliation":[{"name":"Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research (NIDCR) National Institutes of Health (NIH) Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gash","sequence":"additional","affiliation":[{"name":"NPS Pharmaceuticals, Inc., Bedminster NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Gelb","sequence":"additional","affiliation":[{"name":"NPS Pharmaceuticals, Inc., Bedminster NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Krusinska","sequence":"additional","affiliation":[{"name":"NPS Pharmaceuticals, Inc., Bedminster NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C","family":"Brennan","sequence":"additional","affiliation":[{"name":"School of Life and Environmental Science, University of Sydney, Sydney NSW Australia"},{"name":"School of Biosciences, Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schepelmann","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research Medical University of Vienna Vienna Austria"},{"name":"School of Biosciences, Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Riccardi","sequence":"additional","affiliation":[{"name":"School of Biosciences, Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Ezuan","family":"Bin Khayat","sequence":"additional","affiliation":[{"name":"Faculty of Biotechnology and Biomolecular Sciences University Putra Malaysia Selangor Malaysia"},{"name":"Faculty of Biology, Medicine, and Health The University of Manchester Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald T","family":"Ward","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research Medical University of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F","family":"Nemeth","sequence":"additional","affiliation":[{"name":"MetisMedica Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Rosskamp","sequence":"additional","affiliation":[{"name":"NPS Pharmaceuticals, Inc., Bedminster NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Collins","sequence":"additional","affiliation":[{"name":"Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research (NIDCR) National Institutes of Health (NIH) Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"issue":"15","key":"2024021014434117600_jbmr3747-bib-0001","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med"},{"issue":"5","key":"2024021014434117600_jbmr3747-bib-0002","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/hmg\/5.5.601","article-title":"Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism","volume":"5","author":"Baron","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"6455","key":"2024021014434117600_jbmr3747-bib-0003","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature."},{"issue":"11","key":"2024021014434117600_jbmr3747-bib-0004","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1016\/S0021-9258(18)61172-X","article-title":"Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor","volume":"262","author":"Nemeth","year":"1987","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"2024021014434117600_jbmr3747-bib-0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1242\/jeb.200.2.295","article-title":"Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis","volume":"200","author":"Hebert","year":"1997","journal-title":"J Exp Biol"},{"issue":"26","key":"2024021014434117600_jbmr3747-bib-0006","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"issue":"26","key":"2024021014434117600_jbmr3747-bib-0007","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1056\/NEJMc1300278","article-title":"Germline mutations affecting Galpha11 in hypoparathyroidism","volume":"368","author":"Mannstadt","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"2024021014434117600_jbmr3747-bib-0008","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jbmr.2797","article-title":"Identification of a G-protein subunit-alpha11 gain-of-function mutation, Val340Met, in a family with autosomal dominant hypocalcemia type 2 (ADH2)","volume":"31","author":"Piret","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024021014434117600_jbmr3747-bib-0009","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024021014434117600_jbmr3747-bib-0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2016.00458","article-title":"Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2","volume":"7","author":"Roszko","year":"2016","journal-title":"Front Physiol."},{"issue":"2","key":"2024021014434117600_jbmr3747-bib-0011","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2009.09.028","article-title":"An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation","volume":"46","author":"Kumar","year":"2010","journal-title":"Bone."},{"issue":"9","key":"2024021014434117600_jbmr3747-bib-0012","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI57407","article-title":"PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor","volume":"122","author":"Loupy","year":"2012","journal-title":"J Clin Invest"},{"issue":"10","key":"2024021014434117600_jbmr3747-bib-0013","doi-asserted-by":"crossref","first-page":"E229","DOI":"10.1210\/jc.2010-0651","article-title":"Novel activating mutations of the calcium-sensing receptor: the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptors","volume":"95","author":"Letz","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024021014434117600_jbmr3747-bib-0014","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/en.2015-1269","article-title":"The calcilytic agent NPS 2143 Rectifies hypocalcemia in a mouse model with an activating calcium-sensing receptor (CaSR) mutation: relevance to autosomal dominant hypocalcemia type 1 (ADH1)","volume":"156","author":"Hannan","year":"2015","journal-title":"Endocrinology."},{"issue":"37","key":"2024021014434117600_jbmr3747-bib-0015","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.0405516101","article-title":"Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification","volume":"101","author":"Hough","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2024021014434117600_jbmr3747-bib-0016","doi-asserted-by":"crossref","first-page":"e91103","DOI":"10.1172\/jci.insight.91103","article-title":"Galpha11 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy","volume":"2","author":"Gorvin","year":"2017","journal-title":"JCI Insight."},{"issue":"3","key":"2024021014434117600_jbmr3747-bib-0017","doi-asserted-by":"crossref","first-page":"e91079","DOI":"10.1172\/jci.insight.91079","article-title":"Knockin mouse with mutant Galpha11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors","volume":"2","author":"Roszko","year":"2017","journal-title":"JCI Insight."},{"issue":"11","key":"2024021014434117600_jbmr3747-bib-0018","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jbmr.2551","article-title":"Calcilytic ameliorates abnormalities of mutant calcium-sensing receptor (CaSR) knock-in mice mimicking autosomal dominant hypocalcemia (ADH)","volume":"30","author":"Dong","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2024021014434117600_jbmr3747-bib-0019","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1172\/JCI119359","article-title":"Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"99","author":"Bai","year":"1997","journal-title":"J Clin Invest"},{"issue":"18","key":"2024021014434117600_jbmr3747-bib-0020","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.febslet.2014.07.022","article-title":"Roles of intraloops-2 and -3 and the proximal C-terminus in signalling pathway selection from the human calcium-sensing receptor","volume":"588","author":"Goolam","year":"2014","journal-title":"FEBS Lett"},{"issue":"6","key":"2024021014434117600_jbmr3747-bib-0021","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/01.ASN.0000015623.73739.B8","article-title":"Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor","volume":"13","author":"Ward","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2024021014434117600_jbmr3747-bib-0022","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"2024021014434117600_jbmr3747-bib-0023","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024021014434117600_jbmr3747-bib-0024","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study","volume":"36","author":"Clarke","year":"2014","journal-title":"Clin Ther."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.3747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.3747","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/34\/9\/1609\/56653802\/jbmr3747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/34\/9\/1609\/56653802\/jbmr3747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:04:07Z","timestamp":1710327847000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/34\/9\/1609-1618\/7605768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,5,7]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3747","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9,1]]},"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"2018-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}